The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
MOLMOL: A program for display and analysis of macromolecular structures
Koradi, R., Billeter, M., & Wüthrich, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00009-4 · Cited by 7,163
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
The program XEASY for computer-supported NMR spectral analysis of biological macromolecules
Bartels, C., Xia, T.-H., Billeter, M., G�ntert, P., & W�thrich, K. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00417486 · Cited by 1,632
Translational control of gene expression
Sonenberg, N., Hershey, J. W. B., & Mathews, M. B. (2000) · Cold Spring Harbor Laboratory eBooks · Cited by 1,379
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Pause, A., Belsham, G. J., Gingras, A.-C., Donzé, O., Lin, T.-A., Lawrence, J. C., & Sonenberg, N. (1994) · Nature · doi:10.1038/371762a0 · Cited by 1,239
Translational control of gene expression
Hannig, E. M. (2001) · BioEssays · doi:10.1002/bies.1108 · Cited by 1,189
Current development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Regulation of cap-dependent translation by eIF4E inhibitory proteins
Richter, J. D., & Sonenberg, N. (2005) · Nature · doi:10.1038/nature03205 · Cited by 970
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Hierarchical phosphorylation of the translation inhibitor 4E-BP1
Gingras, A.-C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.912401 · Cited by 883
eIF-4E expression and its role in malignancies and metastases
De Benedetti, A., & Graff, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207545 · Cited by 728
Gene-Specific Regulation by General Translation Factors
Dever, T. E. (2002) · Cell · doi:10.1016/s0092-8674(02)00642-6 · Cited by 719
Mader, S., Lee, H., Pause, A., & Sonenberg, N. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4990 · Cited by 683
Haghighat, A., Mader, S., Pause, A., & Sonenberg, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00257.x · Cited by 612
mTOR, translation initiation and cancer
Mamane, Y., Petroulakis, E., LeBacquer, O., & Sonenberg, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209888 · Cited by 607
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 586
Daley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 572
Cap-Dependent Translation Initiation in Eukaryotes Is Regulated by a Molecular Mimic of eIF4G
Marcotrigiano, J., Gingras, A.-C., Sonenberg, N., & Burley, S. K. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80003-4 · Cited by 512
SVITKIN, Y. V., PAUSE, A., HAGHIGHAT, A., PYRONNET, S., WITHERELL, G., BELSHAM, G. J., & SONENBERG, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477
Translational Control of Protein Synthesis
Lodish, H. F. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.000351 · Cited by 452
Targeting mTOR signaling for cancer therapy
Huang, S. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00071-7 · Cited by 436
Koromilas, A. E., Lazaris-Karatzas, A., & Sonenberg, N. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05508.x · Cited by 419
Structure of translation factor elF4E bound to m7GDP and interaction with 4E-binding protein
Matsuo, H., Li, H., McGuire, A. M., Fletcher, C. M., Gingras, A.-C., Sonenberg, N., & Wagner, G. (1997) · Nature Structural Biology · doi:10.1038/nsb0997-717 · Cited by 377
Self-citationFunctional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
Bordeleau, M.-E., Mori, A., Oberer, M., Lindqvist, L., Chard, L. S., Higa, T., Belsham, G. J., Wagner, G., Tanaka, J., & Pelletier, J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio776 · Cited by 366
Self-citationThree-dimensional structure of ectatomin from Ectatomma tuberculatum ant venom
Nolde, D. E., Sobol, A. G., Pluzhnikov, K. A., Grishin, E. V., & Arseniev, A. S. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00227465 · Cited by 363
Ribosome Loading onto the mRNA Cap Is Driven by Conformational Coupling between eIF4G and eIF4E
Gross, J. D., Moerke, N. J., von der Haar, T., Lugovskoy, A. A., Sachs, A. B., McCarthy, J. E. G., & Wagner, G. (2003) · Cell · doi:10.1016/s0092-8674(03)00975-9 · Cited by 346
Self-citationAvdulov, S., Li, S., Michalek, V., Burrichter, D., Peterson, M., Perlman, D. M., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 340
The implications of structured 5′ untranslated regions on translation and disease
Pickering, B. M., & Willis, A. E. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.11.006 · Cited by 339
mTOR, translational control and human disease
Tee, A. R., & Blenis, J. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.11.005 · Cited by 320
Wilson, J. E., Powell, M. J., Hoover, S. E., & Sarnow, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.4990-4999.2000 · Cited by 317
Roehrl, M. H. A., Wang, J. Y., & Wagner, G. (2004) · Biochemistry · doi:10.1021/bi048233g · Cited by 259
Self-citationPestova, T. V., & Hellen, C. U. T. (2003) · Genes & Development · doi:10.1101/gad.1040803 · Cited by 248
The mRNA cap-binding protein eIF4E in post-transcriptional gene expression
von der Haar, T., Gross, J. D., Wagner, G., & McCarthy, J. E. G. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb779 · Cited by 233
Self-citationBordeleau, M.-E., Matthews, J., Wojnar, J. M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P., Teesdale-Spittle, P., & Pelletier, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504249102 · Cited by 228
The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth.
Rousseau, D. L., Gingras, A., Pause, A., & Sonenberg, N. (1996) · PubMed · Cited by 220
When translation meets transformation: the mTOR story
Averous, J., & Proud, C. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209887 · Cited by 197
Will mTOR inhibitors make it as cancer drugs?
Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00275-7 · Cited by 190
mTOR pathway as a target in tissue hypertrophy
Lee, C.-H., Inoki, K., & Guan, K.-L. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105359 · Cited by 179
Altmann, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1114 · Cited by 173
mTOR signaling: implications for cancer and anticancer therapy
Petroulakis, E., Mamane, Y., Le Bacquer, O., Shahbazian, D., & Sonenberg, N. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602902 · Cited by 170
A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins
Zhou, P., Lugovskoy, A. A., & Wagner, G. (2001) · Journal of Biomolecular NMR · doi:10.1023/a:1011258906244 · Cited by 159
Self-citationMalignant transformation by overproduction of translation initiation factor eIF4G.
Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., EKIMOTO, H., & Igarashi, K. (1997) · PubMed · Cited by 159
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen
Novac, O., Guenier, A.-S., & Pelletier, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh235 · Cited by 139
Translational Control of the Antiapoptotic Function of Ras
Polunovsky, V. A., Gingras, A., Sonenberg, N., Peterson, M., Tan, A., Rubins, J. B., Manivel, J. C., & Bitterman, P. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001938200 · Cited by 117
Li, S., Sonenberg, N., Gingras, A., Peterson, M., Avdulov, S. V., Polunovsky, V. A., & Bitterman, P. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2853-2861.2002 · Cited by 100
Hershey, P. E. C., McWhirter, S. M., Gross, J. D., Wagner, G., Alber, T., & Sachs, A. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21297 · Cited by 90
Self-citationEdery, I., Altmann, M., & Sonenberg, N. (1988) · Gene · doi:10.1016/0378-1119(88)90184-9 · Cited by 87
DeFatta, R. J., Nathan, C. O., & Benedetti, A. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200006000-00007 · Cited by 87
Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E
Herbert, T. P., Fåhræus, R., Prescott, A. R., Lane, D. P., & Proud, C. G. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00567-4 · Cited by 85
Fan, Y.-H., Chen, H., Natarajan, A., Guo, Y., Harbinski, F., Iyasere, J., Christ, W. J., Aktaş, H., & Halperin, J. A. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.087 · Cited by 43
Self-citationMiura, T., Shiratori, Y., & Shimma, N. (2003) · Journal of Biomolecular NMR · doi:10.1023/a:1025442322316 · Cited by 4
Cited by
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304
“Another study generated compounds that inhibit the eIF4E-eIF4G interaction and retard the growth of tumor cells (Moerke et al., 2007).”
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
PI3K and cancer: lessons, challenges and opportunities
Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,709
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
Translational control in cancer
Silvera, D., Formenti, S. C., & Schneider, R. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2824 · Cited by 821
Metadata
- Authors
- Moerke, N. J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M. Y., Fahmy, A., Gross, J. D., Degterev, A., Yuan, J., Chorev, M., Halperin, J. A., & Wagner, G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 128
- Issue
- 2
- Pages
- 257-267
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2161011316
- Cited by
- 572
- References
- 58
- FWCI
- 11.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.